cik0-202503050001584509false00015845092023-02-032023-02-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K
____________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934 | | | | | | | | | | | |
March 5, 2025 |
Date of Report (Date of earliest event reported) ____________________________ |
Aramark |
(Exact name of Registrant as Specified in its Charter) ____________________________ |
Delaware | 001-36223 | 20-8236097 |
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
2400 Market Street | | 19103 |
Philadelphia, | Pennsylvania | |
(Address of Principal Executive Offices) | | (Zip Code) |
| | | | | | | | | | | |
(215) | 238-3000 |
(Registrant's Telephone Number, Including Area Code) |
N/A (Former name or former address, if changed since last report.) |
__________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on which Registered |
Common Stock, | par value $0.01 per share | ARMK | New York Stock Exchange |
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On March 5, 2025, Aramark announced the pricing of its previously announced private offering of €400,000,000 aggregate principal amount of 4.375% senior unsecured notes due 2033 (the “Notes”) by its indirect wholly owned subsidiary, Aramark International Finance S.à r.l. (the “Issuer”).
The Issuer intends to use a portion of the net proceeds from the issuance and sale of the Notes to repay at maturity all of the €325,000,000 outstanding aggregate principal amount of the Issuer’s 3.125% Senior Notes due 2025, which mature on April 1, 2025, and the remainder for general corporate purposes. These transactions are anticipated to be net leverage neutral. The offering of the Notes is expected to close on March 19, 2025, subject to customary closing conditions.
The offering of the Notes will be made in a private transaction in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), only to investors who are reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the Securities Act, or outside the United States in accordance with Regulation S under the Securities Act.
This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy the Notes. The Notes have not been registered under the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.
| | | | | |
Item 9.01. | Financial Statements and Exhibits. |
| | | | | | | | | | | |
|
| | | |
Exhibit No. | | | Description |
| |
104 | | | Cover Page Interactive Date File (embedded within the Inline XBRL document). |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | | | | | | | |
| | | Aramark |
| | | | |
Date: | March 5, 2025 | | By: | /S/ JAMES J. TARANGELO |
| | | Name: | JAMES J. TARANGELO |
| | | Title: | Senior Vice President and |
| | | | Chief Financial Officer |